Clinical Trial Update: Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of bevacizumab, pemetrexed, and erlotinib in elderly patients with non-small cell lung cancer was terminated; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2010-08-30